Pranoprofen
- Level
- Commodity
- Parent
- 51384500
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51384516This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C15H13NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2R7O1ET613, chemically known as 5h-(1)benzopyrano(2,3,-b)pyridine-7-acetic acid, alpha-methyl- but generally known as pranoprofen, which bears US NIH Compound Identifier 4888. European Medicines Agency schedules Pranoprofen in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10000MIG. The term PRANOPROFEN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). World Health Organization schedules pranoprofen in its Anatomical Therapeutic Chemical (ATC) Classification. PRANOPROFEN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pranoprofen under HS 29349990 and SITC 51579. As of Q4 2014, PRANOPROFEN remains the US FDA Preferred Term for this commodity. Pranoprofen bears US NLM identifiers UMLS ID C0072652 and NCI Concept Code C73092. SMILES: O1C2C(CC3C1NCCC3)CC(C(C)C(=O)O)CC2.
Same parent
Under 51384500 · 34Activities that produce or sell this
KBLI · 9Inherited from family 51380000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.